OVERACTIVE, BLADDER: A NEW VIEW ON THE PROBLEM
- Autores: ERMAKOVA E.I1, BALAN V.E1
-
Afiliações:
- Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
- Edição: Nº 2 (2011)
- Páginas: 32-35
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/246473
- ID: 246473
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
The paper gives the present view on the etiology, pathogenesis, diagnosis, and treatment of overactive bladder in women.
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
E. ERMAKOVA
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Email: ermakova.health@mail.ru
V. BALAN
Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of Russia
Bibliografia
- Балан В.Е., Гаджиева З.К. Нарушения мочеиспускания в климактерии и принципы их лечения // Рус. мед. журн. — 2000. — Т. 8, № 7. — С. 284.
- Вишневский Е.Л., Пушкарь Д.Ю., Лоран О.Б., Данилов B.В., Вишневский А.Е. Урофлоуметрия. — М., 2004. — C. 176—283.
- Гаджиева З.К. Функциональное состояние нижних мочевых путей и медикаментозная коррекция нарушений мочеиспускания у женщин в климактерии: Дис.. канд. мед. наук. — М., 2001.
- Кулаков В.И., Аполихина И.А. Недержание мочи у женщин: новые возможности в диагностике и лечении // Гинекология. — 2004. — Т. 4, № 3. — С. 103—105.
- Петрова В.Д. Недержание мочи у женщин (этиопатогенез, клиника, диагностика, лечение): Дис.. докт. мед. наук. — М., 2005.
- Сивков А.В., Ромих В.В. Фармакотерапия гиперактивного мочевого пузыря // Consilium medicum. — 2002. — № 7. — С. 348—354.
- Aggazzotti G., Pesce F., Grassi D. et al. Prevalence of urinary incontinence among institutionalized patients: a crosssectional epidemiologic study in a midsized city in northern Italy // Urology. — 2000. — Vol. 156, № 2. — P. 245- 249.
- Covaceuszach S., Cassetta A., Konarev P.V. et al. Dissecting NGF interactions with TrkA and p75 receptors by structural and functional studies of an anti-NGF neutralizing antibody // J. Mol. Biol. — 2008. — Vol. 12, № 381(4). — Р. 881—896.
- Cruz F. Vanilloid receptor and detrusor instability // Urology. — 2002. — Vol. 5 (Suppl 1). — P. 51-60.
- Cardozo L., Staskin D. Textbook of female urology and urogynaecology. — 2005. — P. 183-227.
- Fitzgerald M.P., Brubaker L. Urinary incontinence symptom scores and urodynamic diagnoses. // Neurourol. Urodin. — 2002. — Vol. 21, № 1. — P. 30—35.
- Joon C. K., Doo B.K., Seong S. et al. Nerve growth factor and vanilloid receptor expression and detrusor instability after relieving bladder outlet obstruction in rats // BJU International. — 2004. — Vol. 94. — P. 915-918.
- Kuo H.C., Liu H.T., Chancellor M.B. Urinary Nerve Growth Factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence // Neurology and Urodynamics. — 2010. — Vol. 29, № 3. — P. 482—487.
- Lingman K. Genuine stress incontinence // Current Obstet Gynecol. — 2001. — Vol. 2. — P. 353—358.
- Liu H.T., Kuo H.C. Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention // Neurourol Urodyn. — 2009. — Vol. 28, № 1. — Р. 78—81.
- Liu H.T., Tyagi P., Chancellor M.B. et al. Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment // BJU International. — 2009. — Vol. 104, № 10. — P. 1476—1481.
- Маdersbacher S., Haidinger G., Waldmuller J. Urinary incontinence in both sexes-prevalence rates, impact on quality of life and sexual life. // Eur. Urol. — 2000. — Vol. 37. — P. 2.
- Monz D., Pons M., Hampel C. et al. Patien — repoted impact of urinary incontinence. — Results from treatment seeking women in 14 European countries // Maturitas. — 2005. -Vol. 52, № 2. — Р. 25—28.
- Moore K.H. Conservative management for urinary incontinence // Baillieres Best. Pract. Res. Clin. Obstet. Gynecol. — 2000. — Vol. 14, № 2. — Р. 251-289.
- Van de Vaart C.H., van der Bom J.G., de Leeuw J.R. et al. The contribution of hysterectomy to the occurrence of urge and stress urinary incontinence symptoms // Br. J. Obstet Gynecol. — 2002. — Vol. 109, № 2. — P. 149—151.
- Yokoyama T., Kumon H., Nagai A. Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder // Neurourol. Urodin. — 2008. — Vol. 27. — P. 417—420.
Arquivos suplementares
![](/img/style/loading.gif)